Catalyst Wire Dossier Catalyst Wire Dossier

Gentuximab

gentuximab · Changchun GeneScience Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Gentuximab, covering 2017-12-12 to 2023-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma. [Phase 3]

See pricing